[Therapeutic results in cerebral functional insuffiency using EP 50-100].
D000328:Adult; D000368:Aged; D004220:Disulfides / Q000627:therapeutic use; D004328:Drive; D004338:Drug Combinations / Q000627:therapeutic use; D005221:Fatigue / Q000188:drug therapy; D005260:Female; D006801:Humans; D008297:Male; D008568:Memory / Q000187:drug effects; D008875:Middle Aged; D009440:Neurasthenia / Q000188:drug therapy*; D011725:Pyridines / Q000627:therapeutic use*; D011736:Pyridoxine / Q000627:therapeutic use*; D014717:Vertigo / Q000188:drug therapy
D004220:Disulfides; D004338:Drug Combinations; D011725:Pyridines; D011736:Pyridoxine
Ergebnisse der Behandlung zerebraler Leistungsinsuffizienz mit EP 50-100.